UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group

Journal of clinical oncology, 2007-03, Vol.25 (7), p.820-828

2007

Volltextzugriff (PDF)

Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy

Clinical cancer research, 2008-03, Vol.14 (6), p.1767-1774

2008

Volltextzugriff (PDF)

Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor–dependent mechanism: relationship between the procoagulant and permeability effects of TNF

Blood, 2002-08, Vol.100 (4), p.1334-1339

2002

Volltextzugriff (PDF)

Low p27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor–Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy

Clinical cancer research, 2009-09, Vol.15 (18), p.5888-5894

2009

Volltextzugriff (PDF)

Preoperative therapy with epidoxorubicin and docetaxel plus trastuzumab in patients with primary breast cancer: a pilot study

Journal of cancer research and clinical oncology, 2004-07, Vol.130 (7), p.400-404

2004

Volltextzugriff (PDF)

Abstract P1-02-06: Prediction of Prosigna® breast cancer intrinsic subtype by immunohistochemical ER, PR and Ki67 expression

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-02-06

2022

Volltextzugriff (PDF)

Tumor antigen pulsed dendritic cells enhance the cytolytic activity of tumor infiltrating lymphocytes in human hepatocellular cancer

Cancer biotherapy & radiopharmaceuticals, 2000-10, Vol.15 (5), p.477-486

2000

Volltextzugriff (PDF)

Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancer

Anti-cancer drugs, 2005-04, Vol.16 (4), p.441-445

2005

Volltextzugriff (PDF)

Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer

Cancer chemotherapy and pharmacology, 2002-08, Vol.50 (2), p.155-159

2002

Volltextzugriff (PDF)

Combined analysis of two phase II trials in patients with primary and advanced breast cancer with epidoxorubicin and docetaxel+granulocyte colony stimulating factor

Anti-cancer drugs, 2002-01, Vol.13 (1), p.67-74

2002

Volltextzugriff (PDF)

Preoperative second-line chemotherapy induces objective responses in primary breast cancer

Wiener Klinische Wochenschrift, 2005-01, Vol.117 (1-2), p.48-52

2005

Volltextzugriff (PDF)

Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice

Cancer research (Chicago, Ill.), 1999-07, Vol.59 (14), p.3396-3403

1999

Volltextzugriff (PDF)

Young Age as an Independent Adverse Prognostic Factor in Premenopausal Patients with Breast Cancer

Clinical breast cancer, 2002-04, Vol.3 (1), p.65-72

2002

Volltextzugriff (PDF)

The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinoma

Journal of cancer research and clinical oncology, 1997-06, Vol.123 (6), p.317-324

1997

Volltextzugriff (PDF)

Tumor-specific gene delivery using recombinant vaccinia virus in a rabbit model of liver metastases

JNCI : Journal of the National Cancer Institute, 1999-10, Vol.91 (20), p.1744-1750

1999

Volltextzugriff (PDF)

Inosine 5′-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells

Clinica chimica acta, 2006-02, Vol.364 (1), p.139-147

2006

Volltextzugriff (PDF)

Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases

Annals of surgery, 1999-09, Vol.230 (3), p.352-60; discussion 360-1

1999

Volltextzugriff (PDF)

Future directions in the treatment of breast cancer: cellular interventions using dendritic cells

Breast cancer research and treatment, 2003-01, Vol.81 (S1), p.S119-S123

2003

Volltextzugriff (PDF)

Breast cancer and timing of surgery during menstrual cycle. A 5‐year analysis of 385 pre‐menopausal women

International journal of cancer, 1992-11, Vol.52 (5), p.707-712

1992

Volltextzugriff (PDF)

Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patientswith breast cancer

Cancer chemotherapy and pharmacology, 2002-08, Vol.50 (2), p.155

2002

Volltextzugriff (PDF)

Tumor-Specific Gene Delivery Using Recombinant Vaccinia Virus in a Rabbit Model ofLiver Metastases

JNCI : Journal of the National Cancer Institute, 1999-10, Vol.91 (20), p.1744-1750

1999

Volltextzugriff (PDF)

Induction of immunomediated diseases by recombinant human granulocyte-macrophage colony-stimulating factor during cancer treatment?

Journal of immunotherapy, 1999-01, Vol.22 (1), p.85-89

1999

Volltextzugriff (PDF)

Cutaneous side effects in breast cancer patients treated with cytostatic polychemotherapy and rh GM-CSF : immune phenomena or drug toxicity ?

Breast cancer research and treatment, 1995-06, Vol.34 (3), p.213-219

1995

Volltextzugriff (PDF)

Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancer patients

Anti-cancer drugs, 2001-03, Vol.12 (3), p.209-212

2001

Volltextzugriff (PDF)

Double modulation of 5-fluorouracil by high-dose leucovorin and interferon?2b in advanced colorectal cancer: A phase I and a phase II study of weekly administration

Journal of cancer research and clinical oncology, 1994-05, Vol.120 (5), p.314-318

1994

Volltextzugriff (PDF)

1 – 25 von 160

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(151)

Publikationsform

Artikel
(157)
Tagungsberichte
(3)

Sprache

Englisch
(160)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group

Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy

Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor–dependent mechanism: relationship between the procoagulant and permeability effects of TNF

Low p27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor–Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy

Preoperative therapy with epidoxorubicin and docetaxel plus trastuzumab in patients with primary breast cancer: a pilot study

Abstract P1-02-06: Prediction of Prosigna® breast cancer intrinsic subtype by immunohistochemical ER, PR and Ki67 expression

Tumor antigen pulsed dendritic cells enhance the cytolytic activity of tumor infiltrating lymphocytes in human hepatocellular cancer

Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancer

Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer

Combined analysis of two phase II trials in patients with primary and advanced breast cancer with epidoxorubicin and docetaxel+granulocyte colony stimulating factor

Preoperative second-line chemotherapy induces objective responses in primary breast cancer

Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice

Young Age as an Independent Adverse Prognostic Factor in Premenopausal Patients with Breast Cancer

The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinoma

Tumor-specific gene delivery using recombinant vaccinia virus in a rabbit model of liver metastases

Inosine 5′-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells

Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases

Future directions in the treatment of breast cancer: cellular interventions using dendritic cells

Breast cancer and timing of surgery during menstrual cycle. A 5‐year analysis of 385 pre‐menopausal women

Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patientswith breast cancer

Tumor-Specific Gene Delivery Using Recombinant Vaccinia Virus in a Rabbit Model ofLiver Metastases

Induction of immunomediated diseases by recombinant human granulocyte-macrophage colony-stimulating factor during cancer treatment?

Cutaneous side effects in breast cancer patients treated with cytostatic polychemotherapy and rh GM-CSF : immune phenomena or drug toxicity ?

Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancer patients

Double modulation of 5-fluorouracil by high-dose leucovorin and interferon?2b in advanced colorectal cancer: A phase I and a phase II study of weekly administration

Suchergebnisse filtern